scispace - formally typeset
A

Anna Spada

Researcher at University of Milan

Publications -  326
Citations -  13577

Anna Spada is an academic researcher from University of Milan. The author has contributed to research in topics: Pituitary tumors & Acromegaly. The author has an hindex of 60, co-authored 322 publications receiving 12683 citations. Previous affiliations of Anna Spada include Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

Papers
More filters
Journal ArticleDOI

Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism.

TL;DR: The PSH occurrence and its duration are hardly predictable before surgery, and all patients undergoing unilateral adrenalectomy should receive a steroid substitutive therapy.
Journal ArticleDOI

Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration.

TL;DR: GRF induced a clear rise in plasma GH, statistically different from those obtained after placebo or TRH (p less than 0.01), and TRH was completely ineffective in both stimulating GH release and amplifying the secretory GH response to GRF.
Journal ArticleDOI

Growth factors and human pituitary adenomas.

TL;DR: Several lines of evidence indicate that in pituitary tumors growth factors or their receptors may be overexpressed at variable levels and the contribution of these defects in human pituitsary tumorigenesis remains to be established.
Journal ArticleDOI

Hormonal Signaling and Pituitary Adenomas

TL;DR: This review will focus on the possible impact of G proteins and other components of hormone signaling on pituitary tumorigenesis.
Journal ArticleDOI

Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours.

TL;DR: It is demonstrated that FLNA plays a crucial role in SST2 expression and signalling, angiogenesis, cell adhesion and cell migration in P-NETs and in QGP1 cell line, suggesting a possible role of FLNA in determining the different responsiveness to SS analogues observed in P -NET patients.